Drug therapy for hypertension and hyperlipidemia

Coronary heart disease and other vascular complications of hypertension and hyperlipidemia are leading causes of morbidity and mortality and adding to health care costs in the United States. Nonpharmacologic and pharmacologic treatment are available and have been successful in reducing the frequency and severity of these conditions. Appropriate detection, confirmation, evaluation, and treatment of at-risk individuals by the health care provider are the focus of the discussion that follows.